All questions
Specific populations: Gardasil 9 (Human Papillomavirus 9-valent Vaccine, Recombinant) in human papillomavirus vaccination
2 questions · 2 sources
Specific populations questions that apply to every indication of Gardasil 9 are on Gardasil 9 (Human Papillomavirus 9-valent Vaccine, Recombinant), all indications: Specific populations.
Pregnancy and breastfeeding
Can Gardasil 9 be given during pregnancy?
Applies to Pregnant individuals and individuals exposed to Gardasil 9 shortly before or during pregnancy
What pregnancy outcomes were seen after Gardasil 9 exposure?
Applies to Pregnant individuals and individuals exposed to Gardasil 9 shortly before or during pregnancy
“A six-year pregnancy registry for GARDASIL 9 enrolled 185 women who were exposed to
GARDASIL 9 within one month prior to the last menstrual period (LMP) or at any time during pregnancy,
180 of whom were prospectively followed. After excluding elective terminations (n=1), ectopic
pregnancies (n=0) and those lost to follow-up (n=110), there were 69 pregnancies (including one twin
pregnancy) with known outcomes. Of the 69 pregnancies, 5 were in women exposed twice during
pregnancy. Therefore, there were 74 exposures to GARDASIL 9 during pregnancy: 3 occurred during the
30 days prior to LMP, 34 during the first trimester, 13 during the second trimester, 19 during the third
trimester, and 5 in an unknown trimester. Adverse pregnancy outcomes included 3 miscarriages (all in
pregnancy exposures during the first trimester) and 3 major birth defects (one each for pregnancy
exposure during the 30 days prior to LMP, first trimester, and second trimester). Women who were
exposed twice during pregnancy had 0 miscarriages and 0 major birth defects. These data do not suggest
an increased risk of major birth defects and miscarriage in women who received GARDASIL 9.” (opens the source at this quote in a new tab)